About 2 results found for searched term "Bezlotoxumab" (0.185 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24591 | Bezlotoxumab | Anti-infection |
| Bezlotoxumab is a human monoclonal antibody directed against C. difficile toxin B. Bezlotoxumab binds to C. difficile toxin B preventing intestinal epithelial damage and colitis. | ||
| M24590 | Actoxumab | Others |
| Anti-C. difficile Toxin A Recombinant Antibody | ||
| Actoxumab (Anti-C. difficile Toxin A Recombinant Antibody) is a antitoxin antibody against C. difficile toxin A by neutralizing TcdA. Actoxumab prevents both the damage to the gut wall and the inflammatory response, which are associated with C. difficile. Actoxumab has synergy effect with Bezlotoxumab targeting TcdB. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
